Abstract
Summary
The global Genomics Solutions market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Genomics Solutions is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Genomics Solutions is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Genomics Solutions is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Genomics Solutions players cover 10X Genomics Inc., Abcam Plc, Exeter Clinical Laboratory, Psomagen, BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Danaher Corp., Eppendorf AG and Eurofins Scientific SE, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Genomics Solutions Industry Forecast” looks at past sales and reviews total world Genomics Solutions sales in 2022, providing a comprehensive analysis by region and market sector of projected Genomics Solutions sales for 2023 through 2029. With Genomics Solutions sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genomics Solutions industry.
This Insight Report provides a comprehensive analysis of the global Genomics Solutions landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genomics Solutions portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genomics Solutions market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genomics Solutions and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genomics Solutions.
This report presents a comprehensive overview, market shares, and growth opportunities of Genomics Solutions market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Nucleic Acids Extraction and QC
Gene Expression Services
Genotyping Services and Pharmacogenomics
Data Analysis and Interpretation
Others
Segmentation by application
Hospitals and Clinics
Pharmaceutical
Research Institutes
Agrochemical
Chemical
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
10X Genomics Inc.
Abcam Plc
Exeter Clinical Laboratory
Psomagen
BGI Genomics Co. Ltd.
Bio Rad Laboratories Inc.
Danaher Corp.
Eppendorf AG
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd.
CD Genomics
Illumina
qGenomics
IQVIA
Beckman Coulter
United States market for Genomics Solutions is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Genomics Solutions is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Genomics Solutions is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Genomics Solutions players cover 10X Genomics Inc., Abcam Plc, Exeter Clinical Laboratory, Psomagen, BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Danaher Corp., Eppendorf AG and Eurofins Scientific SE, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Genomics Solutions Industry Forecast” looks at past sales and reviews total world Genomics Solutions sales in 2022, providing a comprehensive analysis by region and market sector of projected Genomics Solutions sales for 2023 through 2029. With Genomics Solutions sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genomics Solutions industry.
This Insight Report provides a comprehensive analysis of the global Genomics Solutions landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genomics Solutions portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genomics Solutions market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genomics Solutions and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genomics Solutions.
This report presents a comprehensive overview, market shares, and growth opportunities of Genomics Solutions market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Nucleic Acids Extraction and QC
Gene Expression Services
Genotyping Services and Pharmacogenomics
Data Analysis and Interpretation
Others
Segmentation by application
Hospitals and Clinics
Pharmaceutical
Research Institutes
Agrochemical
Chemical
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
10X Genomics Inc.
Abcam Plc
Exeter Clinical Laboratory
Psomagen
BGI Genomics Co. Ltd.
Bio Rad Laboratories Inc.
Danaher Corp.
Eppendorf AG
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd.
CD Genomics
Illumina
qGenomics
IQVIA
Beckman Coulter
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Genomics Solutions Market Size 2018-2029
2.1.2 Genomics Solutions Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Genomics Solutions Segment by Type
2.2.1 Nucleic Acids Extraction and QC
2.2.2 Gene Expression Services
2.2.3 Genotyping Services and Pharmacogenomics
2.2.4 Data Analysis and Interpretation
2.2.5 Others
2.3 Genomics Solutions Market Size by Type
2.3.1 Genomics Solutions Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Genomics Solutions Market Size Market Share by Type (2018-2023)
2.4 Genomics Solutions Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Pharmaceutical
2.4.3 Research Institutes
2.4.4 Agrochemical
2.4.5 Chemical
2.4.6 Others
2.5 Genomics Solutions Market Size by Application
2.5.1 Genomics Solutions Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Genomics Solutions Market Size Market Share by Application (2018-2023)
3 Genomics Solutions Market Size by Player
3.1 Genomics Solutions Market Size Market Share by Players
3.1.1 Global Genomics Solutions Revenue by Players (2018-2023)
3.1.2 Global Genomics Solutions Revenue Market Share by Players (2018-2023)
3.2 Global Genomics Solutions Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Genomics Solutions by Regions
4.1 Genomics Solutions Market Size by Regions (2018-2023)
4.2 Americas Genomics Solutions Market Size Growth (2018-2023)
4.3 APAC Genomics Solutions Market Size Growth (2018-2023)
4.4 Europe Genomics Solutions Market Size Growth (2018-2023)
4.5 Middle East & Africa Genomics Solutions Market Size Growth (2018-2023)
5 Americas
5.1 Americas Genomics Solutions Market Size by Country (2018-2023)
5.2 Americas Genomics Solutions Market Size by Type (2018-2023)
5.3 Americas Genomics Solutions Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genomics Solutions Market Size by Region (2018-2023)
6.2 APAC Genomics Solutions Market Size by Type (2018-2023)
6.3 APAC Genomics Solutions Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Genomics Solutions by Country (2018-2023)
7.2 Europe Genomics Solutions Market Size by Type (2018-2023)
7.3 Europe Genomics Solutions Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Genomics Solutions by Region (2018-2023)
8.2 Middle East & Africa Genomics Solutions Market Size by Type (2018-2023)
8.3 Middle East & Africa Genomics Solutions Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Genomics Solutions Market Forecast
10.1 Global Genomics Solutions Forecast by Regions (2024-2029)
10.1.1 Global Genomics Solutions Forecast by Regions (2024-2029)
10.1.2 Americas Genomics Solutions Forecast
10.1.3 APAC Genomics Solutions Forecast
10.1.4 Europe Genomics Solutions Forecast
10.1.5 Middle East & Africa Genomics Solutions Forecast
10.2 Americas Genomics Solutions Forecast by Country (2024-2029)
10.2.1 United States Genomics Solutions Market Forecast
10.2.2 Canada Genomics Solutions Market Forecast
10.2.3 Mexico Genomics Solutions Market Forecast
10.2.4 Brazil Genomics Solutions Market Forecast
10.3 APAC Genomics Solutions Forecast by Region (2024-2029)
10.3.1 China Genomics Solutions Market Forecast
10.3.2 Japan Genomics Solutions Market Forecast
10.3.3 Korea Genomics Solutions Market Forecast
10.3.4 Southeast Asia Genomics Solutions Market Forecast
10.3.5 India Genomics Solutions Market Forecast
10.3.6 Australia Genomics Solutions Market Forecast
10.4 Europe Genomics Solutions Forecast by Country (2024-2029)
10.4.1 Germany Genomics Solutions Market Forecast
10.4.2 France Genomics Solutions Market Forecast
10.4.3 UK Genomics Solutions Market Forecast
10.4.4 Italy Genomics Solutions Market Forecast
10.4.5 Russia Genomics Solutions Market Forecast
10.5 Middle East & Africa Genomics Solutions Forecast by Region (2024-2029)
10.5.1 Egypt Genomics Solutions Market Forecast
10.5.2 South Africa Genomics Solutions Market Forecast
10.5.3 Israel Genomics Solutions Market Forecast
10.5.4 Turkey Genomics Solutions Market Forecast
10.5.5 GCC Countries Genomics Solutions Market Forecast
10.6 Global Genomics Solutions Forecast by Type (2024-2029)
10.7 Global Genomics Solutions Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 10X Genomics Inc.
11.1.1 10X Genomics Inc. Company Information
11.1.2 10X Genomics Inc. Genomics Solutions Product Offered
11.1.3 10X Genomics Inc. Genomics Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 10X Genomics Inc. Main Business Overview
11.1.5 10X Genomics Inc. Latest Developments
11.2 Abcam Plc
11.2.1 Abcam Plc Company Information
11.2.2 Abcam Plc Genomics Solutions Product Offered
11.2.3 Abcam Plc Genomics Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Abcam Plc Main Business Overview
11.2.5 Abcam Plc Latest Developments
11.3 Exeter Clinical Laboratory
11.3.1 Exeter Clinical Laboratory Company Information
11.3.2 Exeter Clinical Laboratory Genomics Solutions Product Offered
11.3.3 Exeter Clinical Laboratory Genomics Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Exeter Clinical Laboratory Main Business Overview
11.3.5 Exeter Clinical Laboratory Latest Developments
11.4 Psomagen
11.4.1 Psomagen Company Information
11.4.2 Psomagen Genomics Solutions Product Offered
11.4.3 Psomagen Genomics Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Psomagen Main Business Overview
11.4.5 Psomagen Latest Developments
11.5 BGI Genomics Co. Ltd.
11.5.1 BGI Genomics Co. Ltd. Company Information
11.5.2 BGI Genomics Co. Ltd. Genomics Solutions Product Offered
11.5.3 BGI Genomics Co. Ltd. Genomics Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 BGI Genomics Co. Ltd. Main Business Overview
11.5.5 BGI Genomics Co. Ltd. Latest Developments
11.6 Bio Rad Laboratories Inc.
11.6.1 Bio Rad Laboratories Inc. Company Information
11.6.2 Bio Rad Laboratories Inc. Genomics Solutions Product Offered
11.6.3 Bio Rad Laboratories Inc. Genomics Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Bio Rad Laboratories Inc. Main Business Overview
11.6.5 Bio Rad Laboratories Inc. Latest Developments
11.7 Danaher Corp.
11.7.1 Danaher Corp. Company Information
11.7.2 Danaher Corp. Genomics Solutions Product Offered
11.7.3 Danaher Corp. Genomics Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Danaher Corp. Main Business Overview
11.7.5 Danaher Corp. Latest Developments
11.8 Eppendorf AG
11.8.1 Eppendorf AG Company Information
11.8.2 Eppendorf AG Genomics Solutions Product Offered
11.8.3 Eppendorf AG Genomics Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Eppendorf AG Main Business Overview
11.8.5 Eppendorf AG Latest Developments
11.9 Eurofins Scientific SE
11.9.1 Eurofins Scientific SE Company Information
11.9.2 Eurofins Scientific SE Genomics Solutions Product Offered
11.9.3 Eurofins Scientific SE Genomics Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Eurofins Scientific SE Main Business Overview
11.9.5 Eurofins Scientific SE Latest Developments
11.10 F. Hoffmann-La Roche Ltd.
11.10.1 F. Hoffmann-La Roche Ltd. Company Information
11.10.2 F. Hoffmann-La Roche Ltd. Genomics Solutions Product Offered
11.10.3 F. Hoffmann-La Roche Ltd. Genomics Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.10.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.11 CD Genomics
11.11.1 CD Genomics Company Information
11.11.2 CD Genomics Genomics Solutions Product Offered
11.11.3 CD Genomics Genomics Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 CD Genomics Main Business Overview
11.11.5 CD Genomics Latest Developments
11.12 Illumina
11.12.1 Illumina Company Information
11.12.2 Illumina Genomics Solutions Product Offered
11.12.3 Illumina Genomics Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Illumina Main Business Overview
11.12.5 Illumina Latest Developments
11.13 qGenomics
11.13.1 qGenomics Company Information
11.13.2 qGenomics Genomics Solutions Product Offered
11.13.3 qGenomics Genomics Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 qGenomics Main Business Overview
11.13.5 qGenomics Latest Developments
11.14 IQVIA
11.14.1 IQVIA Company Information
11.14.2 IQVIA Genomics Solutions Product Offered
11.14.3 IQVIA Genomics Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 IQVIA Main Business Overview
11.14.5 IQVIA Latest Developments
11.15 Beckman Coulter
11.15.1 Beckman Coulter Company Information
11.15.2 Beckman Coulter Genomics Solutions Product Offered
11.15.3 Beckman Coulter Genomics Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Beckman Coulter Main Business Overview
11.15.5 Beckman Coulter Latest Developments
12 Research Findings and Conclusion